Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1974 Sep;18(1):39–47.

Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis

J M Goust, A Castaigne, R Moulias
PMCID: PMC1537976  PMID: 4478858

Abstract

Delayed hypersensitivity reactions appear to be important in the two main muscular human diseases involving autoimmune anomalies. Using the leucocyte migration test (LMT), a significant abnormality was detected in twelve out of fourteen polymyositis (PM) patients, and in forty out of forty-six myasthenics, in the presence of muscle antigens. No abnormal reactions in the presence of monkey thymus in the LMT were observed amongst the PM patients, as opposed to twenty-one abnormal reactions out of forty-two myasthenics. Secretion of migration inhibition factor (MIF) in the presence of muscular antigens is in accordance with what is known about hypersensitivity reactions during the course of polymyositis. In myasthenia gravis (MG), delayed hypersensitivity to muscle antigens was found to be frequent, and this also applies to thymic antigens, which are considered important in this disease. The role of the T lymphocytes in the neuromuscular junction still remains hypothetical.

Full text

PDF
39

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpert L. I., Papatestas A., Kark A., Osserman R. S., Osserman K. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol. 1971 Jan;91(1):55–61. [PubMed] [Google Scholar]
  2. Bendixen G., Soborg M. A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan Med Bull. 1969 Jan;16(1):1–6. [PubMed] [Google Scholar]
  3. CASPARY E. A., GUBBAY S. S., STERN G. M. CIRCULATING ANTIBODIES IN POLYMYOSITIS AND OTHER MUSCLE-WASTING DISORDERS. Lancet. 1964 Oct 31;2(7366):941–941. doi: 10.1016/s0140-6736(64)90868-2. [DOI] [PubMed] [Google Scholar]
  4. Chou S. M. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol. 1968 Dec;86(6):649–658. [PubMed] [Google Scholar]
  5. Currie S. Experimental myositis: the in-vivo and in-vitro activity of lymph-node cells. J Pathol. 1971 Nov;105(3):169–185. doi: 10.1002/path.1711050304. [DOI] [PubMed] [Google Scholar]
  6. Currie S., Saunders M., Knowles M., Brown A. E. Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med. 1971 Jan;40(157):63–84. [PubMed] [Google Scholar]
  7. Falk R. E., Guttmann R. D., Beaudoin J. G., Morehouse D. D., Oh J. H. Leukocyte migration in vitro and its relationship to human renal allograft rejection and enhancement. Transplantation. 1972 May;13(5):461–466. doi: 10.1097/00007890-197205000-00003. [DOI] [PubMed] [Google Scholar]
  8. Goldstein G., Manganaro A. Thymin: a thymic polypeptide causing the neuromuscular block of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15;183:230–240. doi: 10.1111/j.1749-6632.1971.tb30754.x. [DOI] [PubMed] [Google Scholar]
  9. Goldstein G. The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs. Lancet. 1968 Jul 20;2(7560):119–122. doi: 10.1016/s0140-6736(68)90414-5. [DOI] [PubMed] [Google Scholar]
  10. Goldstein G., Whittingham S. Histological and serological features of experimental autoimmune thymitis in guinea-pigs. Clin Exp Immunol. 1967 May;2(3):257–268. [PMC free article] [PubMed] [Google Scholar]
  11. Houseley J., Oppenheim J. J. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. Br Med J. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson R. L., Fink C. W., Ziff M. Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest. 1972 Sep;51(9):2435–2449. doi: 10.1172/JCI107057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. KORNFELD P., SIEGAL S., WEINER L. B., OSSERMAN K. E. STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS. Ann Intern Med. 1965 Sep;63:416–428. doi: 10.7326/0003-4819-63-3-416. [DOI] [PubMed] [Google Scholar]
  14. Kakulas B. A. Destruction of differentiated muscle cultures by sensitised lymphoid cells. J Pathol Bacteriol. 1966 Apr;91(2):495–503. doi: 10.1002/path.1700910225. [DOI] [PubMed] [Google Scholar]
  15. Kalden J. R., Williamson W. G., Johnston R. J., Irvine W. J. Studies on experimental autoimmune thymitis in guinea-pigs. Clin Exp Immunol. 1969 Oct;5(4):319–340. [PMC free article] [PubMed] [Google Scholar]
  16. Kott E., Genkins G., Rule A. H. Leukocyte response to muscle antigens in myasthenia gravis. Relationship to clinical severity and presence of circulating antibodies. Neurology. 1973 Apr;23(4):374–380. doi: 10.1212/wnl.23.4.374. [DOI] [PubMed] [Google Scholar]
  17. Mastaglia F. L., Currie S. Immunological and ultrastructural observations on the role of lymphoid cells in the pathogenesis of polymyositis. Acta Neuropathol. 1971;18(1):1–16. doi: 10.1007/BF00684472. [DOI] [PubMed] [Google Scholar]
  18. Oosterhuis H. J., Bethlem J., Feltkamp T. E. Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry. 1968 Oct;31(5):460–463. doi: 10.1136/jnnp.31.5.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Papatestas A. E., Alpert L. I., Osserman K. E., Osserman R. S., Kark A. E. Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969. Am J Med. 1971 Apr;50(4):465–474. doi: 10.1016/0002-9343(71)90336-6. [DOI] [PubMed] [Google Scholar]
  20. Papatestas A. E., Osserman K. E., Kark A. E. The effects of thymectomy on the prognosis in myasthenia gravis. Mt Sinai J Med. 1971 Nov-Dec;38(6):586–593. [PubMed] [Google Scholar]
  21. Rowland L. P. Immunosuppressive drugs in treatment of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15;183:351–357. doi: 10.1111/j.1749-6632.1971.tb30764.x. [DOI] [PubMed] [Google Scholar]
  22. Rule A. H., Kornfeld P. Studies in myasthenia gravis: biologic aspects. Mt Sinai J Med. 1971 Nov-Dec;38(6):538–572. [PubMed] [Google Scholar]
  23. SAHAY B. M., BLENDIS L. M., GREENE R. RELATION BETWEEN MYASTHENIA GRAVIS AND THYROID DISEASE. Br Med J. 1965 Mar 20;1(5437):762–765. doi: 10.1136/bmj.1.5437.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sato T., Walker D. L., Peters H. A., Resse H. H., Chou S. M. Chronic polymyositis and myxovirus-like inclusions. Electron microscopic and viral studies. Arch Neurol. 1971 May;24(5):409–418. doi: 10.1001/archneur.1971.00480350043004. [DOI] [PubMed] [Google Scholar]
  25. Saunders M., Knowles M., Currie S. Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):569–571. doi: 10.1136/jnnp.32.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  27. Soborg M., Halberg P. Cellular hypersensitivity in Hashimoto's thyroiditis. Specific action of thyroid extract upon the migration of leucocytes in vitro. Acta Med Scand. 1968 Jan-Feb;183(1-2):101–105. [PubMed] [Google Scholar]
  28. Stern G. M., Rose A. L., Jacobs K. Circulating antibodies in polymyositis. J Neurol Sci. 1967 Jul-Aug;5(1):181–183. doi: 10.1016/0022-510x(67)90015-9. [DOI] [PubMed] [Google Scholar]
  29. Stevenson R. D. Hydrocortisone and the migration of human leucocytes: an indirect effect mediated by mononuclear cells. Clin Exp Immunol. 1973 Jul;14(3):417–426. [PMC free article] [PubMed] [Google Scholar]
  30. Whitaker J. N., Engel W. K. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972 Feb 17;286(7):333–338. doi: 10.1056/NEJM197202172860701. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES